Trial Profile
Treatment of Radiation Retinopathy With Intravitreal Aflibercept Injection 2.0mg
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Apr 2019
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Macular degeneration
- Focus Adverse reactions
- 24 Apr 2019 Status changed from active, no longer recruiting to completed.
- 30 Apr 2018 Planned End Date changed from 1 Jan 2018 to 1 Jan 2019.
- 30 Apr 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Jan 2019.